Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: Unknown
Life Threatening? No
Write-up: Information received from Merck through agency on 14-DEC-2011. The information was gathered was retrieved from an internet article, a blog about GARDASIL. Case not medically confirmed. According to the article, a female patient, who was 13 years old when she was vaccinated with either the first or the second dose of GARDASIL, received the first dose on 22-SEP-2008 (batch number: NG432200, dose, route not reported). She received the second dose of 24-NOV-2011 (batch#N643220, dose, route not reported). After vaccination (date not reported, it was not reported whether the patient presented the adverse events after the first dose or the second dose of vaccine), she was unable to do physical education. Her medical test showed a low level of potassium- she had tremors, she got sick, she had headaches and experienced loss of sight and dizziness. After being admitted to the emergency unit of the hospital she discharged after 7 hours resting. She had advised to see a psychologist, but her mother said her daughter was not a crazy girl. Her condition became worsening almost always when she had her menstrual cycle. The patient also presented with shaking and tachypnea that took her to the hospital. According to the reporter the patient had not recovered. To be noted that the diagnosis reported was incapacity which was added as serious criteria. The reported batch number for both dose 1 and dose 2 did not exist and the closer batch number distributed was NG43220 (lot # 168U). Other business partner number included: E2011-08230. No further information reported.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166